Biolase (BIOL) Misses Q1 EPS by 4c

Biolase (NASDAQ: BIOL) reported Q1 EPS of ($0.07), $0.04 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $11 million versus the consensus estimate of $11.9 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• Benchmark on Take-Two's (TTWO) GTV 6 Release: 'we anticipate that the game will not be released within the fiscal year and expect it to launch in fiscal 2026 instead'
• Senesco Technologies, Inc. (SNT) Reports Q1 EPS of $0.02
• Safe & Green (SGBX) Provides Update on Audit and Planned 10-K Filing